In line with our study, Thompson et al. found slightly more CD4+ T cells than CD8+ T cells in DCIS [20], and Sheu et al. showed that CD8+ T cells significantly increased with stage progression of invasive breast cancer [38]. This evidence concerns the gene CD8A and invasive breast carcinoma.